Automated Screening System for Modifiers of Cardiac Output in Zebrafish
斑马鱼心输出量调节因素的自动筛选系统
基本信息
- 批准号:7689914
- 负责人:
- 金额:$ 37.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAlgorithmsAnalysis of VarianceAnimal TestingAnimalsAnteriorAortaAutomationBiological AssayBloodBlood flowCaliberCardiacCardiac OutputCardiotoxicityCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCollectionComputer softwareDataData CollectionDetectionDevelopmentDiseaseDorsalEFRACEmbryoEvaluationFishesFundingGovernmentHeartHeart RateHeart failureImageLaboratoriesLarvaLeadLengthLettersLocationMapsMeasurementMeasuresMethodsMicroscopeModelingNatureOptical Coherence TomographyOpticsPersonsPharmaceutical PreparationsPharmacologic SubstancePhasePhase II Clinical TrialsPositioning AttributeProcessProtein Structure InitiativePulsatile FlowResearchResearch DesignResolutionScanningScheduleScreening procedureSpeedStagingStroke VolumeSystemTechnologyTestingTimeToxic effectToxicologyUnited States National Institutes of HealthVentricularVentricular End-Systolic VolumesZebrafishbaseclinically relevantcomputerized data processingdata acquisitiondesigndrug discoverydrug testingheart imaginghigh throughput screeninghuman diseaseimage processingimprovedinstrumentmutantnovelphysical scienceprogramspublic health relevancesmall molecule
项目摘要
DESCRIPTION (provided by applicant): The zebrafish, Danio rerio, has become widely accepted as a model for human disease. Small molecule screens have been performed to identify both modifiers of normal cardiovascular processes and modifiers of cardiovascular disease. High-throughput systems under development aim to measure heart rate but do not address other critical parameters of cardiovascular function such as blood velocity, stroke volume and ejection fraction. We propose to develop a high-throughput system that would simultaneously: 1) measure heart rate; 2) generate a velocity profile of the ventral aorta; and 3) measure end diastolic and end systolic ventricular volume. The microscope-based system will utilize spectral domain optical coherence tomography with Doppler to generate, within a matter of seconds, a three dimensional structural image of zebrafish embryos and larvae and measure blood flow. In Phase I we developed a breadboard system that enabled collection of images from both the dorsal and ventral views of the animals. In the breadboard system the animals were located and the scan angle was adjusted manually. In Phase II a complete, automated screening system will be developed that includes: 1) software algorithms to rapidly locate the animals for imaging and adjust the scan angle along their axial length; 2) automated image collection; and 3) automated image processing. Phase II testing will include a pilot screen to detect animals with decreased cardiac output. PUBLIC HEALTH RELEVANCE: This research will develop technologies that will enable the use of zebrafish models of human disease in high-throughput screens for active pharmaceutical compounds. In particular, such screens are expected to accelerate discovery of new pharmaceuticals to treat cardiovascular diseases. These technologies will also enable high-throughput assays of cardiotoxicity.
描述(由申请人提供):斑马鱼(Danio rerio)已被广泛接受为人类疾病的模型。已经进行小分子筛选来鉴定正常心血管过程的调节剂和心血管疾病的调节剂。正在开发的高通量系统旨在测量心率,但不涉及心血管功能的其他关键参数,例如血流速度、每搏输出量和射血分数。我们建议开发一种高通量系统,该系统可以同时:1)测量心率; 2) 生成腹主动脉的速度分布图; 3) 测量舒张末期和收缩末期心室容积。基于显微镜的系统将利用多普勒谱域光学相干断层扫描在几秒钟内生成斑马鱼胚胎和幼虫的三维结构图像并测量血流。在第一阶段,我们开发了一个面包板系统,可以收集动物的背侧和腹侧视图的图像。在面包板系统中定位动物并手动调整扫描角度。在第二阶段,将开发一个完整的自动筛选系统,包括:1)软件算法,用于快速定位动物进行成像并沿其轴向长度调整扫描角度; 2)自动化图像采集; 3)自动图像处理。第二阶段测试将包括一个试点筛选,以检测心输出量减少的动物。公共健康相关性:这项研究将开发能够在活性药物化合物的高通量筛选中使用人类疾病斑马鱼模型的技术。特别是,此类筛选有望加速治疗心血管疾病的新药物的发现。这些技术还将实现心脏毒性的高通量测定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY A Ferrante其他文献
ANTHONY A Ferrante的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY A Ferrante', 18)}}的其他基金
High Content Discovery Assay for Muscular Dystrophy Therapeutics
肌营养不良疗法的高内涵发现测定
- 批准号:
7802041 - 财政年份:2010
- 资助金额:
$ 37.37万 - 项目类别:
Fully Automated Angiogenesis Drug Discovery Assay in Zebrafish
斑马鱼全自动血管生成药物发现测定
- 批准号:
8441500 - 财政年份:2009
- 资助金额:
$ 37.37万 - 项目类别:
Fully automated angiogenesis drug discovery assay in Zebrafish
斑马鱼全自动血管生成药物发现测定
- 批准号:
7745544 - 财政年份:2009
- 资助金额:
$ 37.37万 - 项目类别:
Fully Automated Angiogenesis Drug Discovery Assay in Zebrafish
斑马鱼全自动血管生成药物发现测定
- 批准号:
8253232 - 财政年份:2009
- 资助金额:
$ 37.37万 - 项目类别:
Novel System for Long-Term Rearing and High-Throughput Assay of Zebrafish
斑马鱼长期饲养和高通量检测的新系统
- 批准号:
7670945 - 财政年份:2009
- 资助金额:
$ 37.37万 - 项目类别:
Novel Intracellular Therapeutic Agent for Botulinum Intoxication
新型肉毒杆菌中毒细胞内治疗剂
- 批准号:
7611019 - 财政年份:2008
- 资助金额:
$ 37.37万 - 项目类别:
Automated Screening System for Modifiers of Cardiac Output in Zebrafish
斑马鱼心输出量调节因素的自动筛选系统
- 批准号:
7537985 - 财政年份:2006
- 资助金额:
$ 37.37万 - 项目类别:
Automated Screening System for Modifiers of Cardiac Output in Zebrafish
斑马鱼心输出量调节因素的自动筛选系统
- 批准号:
7286677 - 财政年份:2006
- 资助金额:
$ 37.37万 - 项目类别:
Automated Screening System for Modifiers of Cardiac Output in Zebrafish
斑马鱼心输出量调节因素的自动筛选系统
- 批准号:
7156129 - 财政年份:2006
- 资助金额:
$ 37.37万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




